Clinigen Clinical Supplies Management
Customised Clinical Supply and Biological Sample Services
Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics for C$4.5m ($3.6m).
Woden Venture Capital (Woden) plans to acquire biotechnology company ACCUM Therapeutics Inc. for C$4.5m ($3.6m).
Both entities involved in the acquisition are based in Canada.
German drug discovery company Evotec plans to acquire Aptuit from Welsh, Carson, Anderson & Stowe (WCAS) for $300m.
Aptuit is a pharmaceutical services provider, while WCAS is a private equity firm. Both companies are based in the US.
The acquisition will create new business opportunities for Evotec and strengthen its market position.
Customised Clinical Supply and Biological Sample Services
Standardized Tools for Cellular Immune Assays
Electronic Data Capture Solutions for Clinical Trials